Grants per year
Personal profile
Research Interests
Neuromuscular Disorders: Amyotrophic Lateral Sclerosis Muscular Dystropy Peripheral Neuropathy
Certifications and Licenses
| Neuromuscular Medicine | |
| Neurology |
Training Experience
| 2004 | Residency, Univ. of Illinois Hospital |
| 2005 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MD, University of Tunis
… → 1996
Research interests
- ALS
- Amyotrophic Lateral Sclerosis
- Muscular Dystrophy
- Nervous System Diseases
- Neuromuscular Disorders
- Peripheral Neuropathy
Fingerprint
Dive into the research topics where Senda Ajroud-Driss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) E to Master Protocol TREHALOSE S-005
Massachusetts General Hospital, NexMed, Inc.
3/1/22 → 12/4/24
Project: Research project
-
Protocol Number: A35-004 - Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of AMX0035 Versus Placebo for 48-week Treatment of Adult Patients with Amyotrophic Lateral Sclerosis (ALS)
Julius Clinical Research B.V, Amylyx Pharmaceuticals, Inc.
1/12/22 → 1/12/25
Project: Research project
-
-
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development
for the Healey ALS Platform Trial Study Group, HEALEY ALS Platform Trial Study Group, Biostatisticians, Investigators, Clinical Operations Team & Medical Monitors, Feb 2022, In: Annals of neurology. 91, 2, p. 165-175 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy
Zelikovich, A. S., Joslin, B. C., Casey, P., McNally, E. M. & Ajroud-Driss, S., 2022, In: Journal of neuromuscular diseases. 9, 2, p. 275-287 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines
Baxi, E. G., Thompson, T., Li, J., Kaye, J. A., Lim, R. G., Wu, J., Ramamoorthy, D., Lima, L., Vaibhav, V., Matlock, A., Frank, A., Coyne, A. N., Landin, B., Ornelas, L., Mosmiller, E., Thrower, S., Farr, S. M., Panther, L., Gomez, E., Galvez, E. & 81 others, , Feb 2022, In: Nature neuroscience. 25, 2, p. 226-237 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor
the VM202 study group, May 2021, In: Clinical and Translational Science. 14, 3, p. 1176-1184 9 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
patisiran Global OLE study group, Jan 2021, In: The Lancet Neurology. 20, 1, p. 49-59 11 p.Research output: Contribution to journal › Article › peer-review
27 Scopus citations